IshirBhanMDMPH

Nephrology • Boston, MA

Physician

Join to view full profile

Dr. Bhan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhan's full profile

Already have an account?

Office
50 Staniford St
# 7
Boston, MA 02114
Phone+1 617-726-3934

Education & Training

Harvard School of Public HealthMPH, Clinical Effectiveness, 2005 - 2008
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2004 - 2008
Massachusetts General HospitalChief Residency, Internal Medicine, 2005 - 2006
Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
Harvard Medical SchoolClass of 2001

Certifications & Licensure

MA State Medical License 2003 - 2026

Clinical Trials

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects Start of enrollment: 2007 Jul 01
Completed
Not Applicable
DIVINE: Dialysis Infection and Vitamin D In New England Start of enrollment: 2009 Nov 01
Completed
Not Applicable
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease Start of enrollment: 2009 Dec 01
Withdrawn
Not Applicable
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients Start of enrollment: 2011 May 01
Terminated
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage Start of enrollment: 2013 Oct 01
Withdrawn
Phase 3
Join now to see all

Publications & Presentations

PubMed

179 citations
Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial.
Jeffrey L. Schnipper, Claus Hamann, Chima D. Ndumele, Catherine Liang, Marcy G. Carty
Archives of Internal Medicine. 2009-04-27
112 citations
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial.
Sadeq A. Quraishi, Gennaro De Pascale, Joseph S. Needleman, Harumasa Nakazawa, Masao Kaneki
Critical Care Medicine. 2015-09-01
60 citations
Vitamin D Binding Protein and Bone Health
Ishir Bhan
International Journal of Endocrinology. 2014-06-01

Lectures

Primary Care Internal Medicine: Principles and Practice
Harvard Medical School ,Department Of Continuing Education, Cambridge, Massachusetts - 10/14/2013
Primary Care Internal Medicine: Principles and Practice
Harvard Medical School ,Department Of Continuing Education, Cambridge, Massachusetts - 10/14/2013

Press Mentions

Why SHPT Remains Difficult to TreatMay 12th, 2016
Vitamin D Treatment Not Found to Reduce Cardiovascular Abnormalities in Kidney Disease PatientsFebruary 14th, 2012
Tests of Resistance to Hormone Could Help Doctors Monitor and Treat Kidney Disease PatientsFebruary 10th, 2016

Grant Support

Human Cathelicidin (HCAP18) In Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011